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ABSTRACT
Introduction: Factor XI deficiency is a rare type of hemophilia. It is associated with profuse 
bleeding after traumas and surgical procedures. In a patient with factor XI deficiency, 
the serum coagulation factor level does not predict bleeding tendency appropriately. 
Operations in sites without fibrinolytic activity are less likely to be complicated by bleeding, 
while surgery in areas with fibrinolytic activity, like prostatectomy, increases the risk of 
bleeding. The optimal treatment should be determined by individual circumstances. Radical 
prostatectomy is a procedure when severe bleeding requiring transfusion can occur even 
without any bleeding disorder. At the same time radical prostatectomy carries a significant 
risk of potentially fatal thromboembolism. Thus keeping the balance between procoagulant 
and anticoagulant activity is the challenging part in cases of radical prostatecomy of factor 
XI deficiency. 
Case Report: A 67-year-old patient is presented with organ confined intermediate-risk 
prostate cancer. Prolonged bleeding after tooth extraction and prostate biopsy indicated 
assessment of hemostatic system. Laboratory tests revealed factor XI deficiency. Successful 
laparoscopic extraperitoneal radical prostatectomy and bilateral pelvic lymphadenectomy 
was performed with low amount of blood loss. Recombinant activated coagulation factor 
VII was administered to prevent perioperative bleeding. The postoperative period was 
uneventful, no complications were observed. 
Conclusion: Despite the high risk of hemorrhage, laparoscopic radical prostatectomy is 
a feasible procedure even in a patient with factor XI deficiency, providing that the patient 
receive adequate preparation and a meticulously performed operation carried out by an 
experienced surgeon.
(This page in not part of the published article.) 
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AbstrAct
Introduction: Factor XI deficiency is a rare type 
of hemophilia. It is associated with profuse 
bleeding after traumas and surgical procedures. 
In a patient with factor XI deficiency, the 
serum coagulation factor level does not predict 
bleeding tendency appropriately. Operations 
in sites without fibrinolytic activity are less 
likely to be complicated by bleeding, while 
surgery in areas with fibrinolytic activity, like 
prostatectomy, increases the risk of bleeding. 
the optimal treatment should be determined by 
individual circumstances. radical prostatectomy 
is a procedure when severe bleeding requiring 
transfusion can occur even without any bleeding 
disorder. At the same time radical prostatectomy 
carries a significant risk of potentially fatal 
thromboembolism. thus keeping the balance 
between procoagulant and anticoagulant 
activity is the challenging part in cases of 
radical prostatecomy of factor XI deficiency. 
case report: A 67-year-old patient is presented 
with organ confined intermediate-risk prostate 
cancer. Prolonged bleeding after tooth extraction 
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and prostate biopsy indicated assessment of 
hemostatic system. Laboratory tests revealed 
factor XI deficiency. successful laparoscopic 
extraperitoneal radical prostatectomy and 
bilateral pelvic lymphadenectomy was 
performed with low amount of blood loss. 
recombinant activated coagulation factor VII 
was administered to prevent perioperative 
bleeding. the postoperative period was 
uneventful, no complications were observed. 
conclusion: Despite the high risk of hemorrhage, 
laparoscopic radical prostatectomy is a feasible 
procedure even in a patient with factor XI 
deficiency, providing that the patient receive 
adequate preparation and a meticulously 
performed operation carried out by an 
experienced surgeon.
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INtrODUctION
Factor XI deficiency is a rare type of hemophilia, 
which can associated with profuse bleeding after surgery. 
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It is also called hemophilia C, plasma thromboplastin 
antecedent (PTA) deficiency and Rosenthal syndrome. 
Rosenthal described first these autosomal hereditary 
blood coagulation disorder in 1953 [1]. Due to its 
autosomal inheritance it affects both men and women, 
unlike hemophilia A and B. It is rare worldwide, but 
considerably common in Ashkenazi Jews. Factor XI 
deficiency is less severe hemophilia than hemophilia A 
and B. Spontaneous bleeding is rare, but severe bleeding 
can occur after traumas and surgical procedures. In 
contrast to hemophilia A and B, the serum coagulation 
factor level does not predict bleeding tendency 
appropriately. Assessment of bleeding risk during 
upcoming surgical procedures is difficult in patients with 
no prior surgeries. Furthermore replacement therapy 
may be associated with risk of thrombosis [2, 3].
A 67-year-old patient is presented with factor XI 
deficiency and prostate cancer. Successful laparoscopic 
radical prostatectomy with lymphadenectomy was 
performed.
cAsE rEPOrt
The 67-year-old patient had a history of hypertension, 
diabetes mellitus and profuse bleeding after extraction 
of a tooth. Elevated (16 ng/ml) prostate specific antigen 
(PSA) level indicated transrectal ultrasound-guided 
prostate biopsy, which revealed Gleason score 4+3=7 
prostate adenocarcinoma. Hematuria occurred and 
lasted for 10 days after the procedure. Hemostasis 
laboratory test revealed factor XI deficiency. The activity 
of factor XI was 15%. Activity of factor VII and VIII were 
in normal range, 123% and 157%, respectively. Thrombin 
time, prothrombin time, international normalized ratio, 
activated partial thromboplastin time, fibrinogen, 
platelet count and platelet function assay test were 
15.4 sec, 8.0 sec, 0.98, 41.0 sec, 3.65 g/L, 187 Giga/L 
and 91 sec, respectively. Staging diagnostical tests 
suggested organ confined prostate cancer. Alternative 
therapeutical options (external beam radiation therapy, 
brachytherapy) were offered, but the patient insisted on 
radical prostatectomy applying laparoscopic approach. 
After hematological consultation laparoscopic 
extraperitoneal radical prostatectomy and bilateral 
pelvic lymphadenectomy was performed. The following 
attempts were done during the procedure to minimize 
bleeding: early ligation of Santorini’s plexus; application 
of a multifunctional ultrasonic and bipolar instrument 
(Thunderbeat - Olympus, Japan) and polymer clips 
(Hem-o-lok – Teleflex, United States) for maximal 
vascular control (Figure 1). Furthermore recombinant 
activated coagulation factor VII (NovoSeven – Novo 
Nordisk, Bagsvaerd, Denmark) was administered during 
the procedure and the postoperative period in order to 
prevent excessive bleeding. First 3 mg dose of factor VII 
was given right before the operation, then 2 mg every 
two hours until 24 hours. On the next day the patient 
received 2 mg factor VII every three hours, thereafter 
on the strength of clinical course. Altogether 63 mg 
coagulation factor VII was dosed. Full blood count, 
thrombin time, prothrombin time, activated partial 
thromboplastin time, fibrinogen and activity of factor 
VII were investigated for monitoring hematological 
status during the postoperative period. First tests were 
done on the morning of the first postoperative day before 
the administration of NovoSeven and thirty minutes 
after the injection, then every morning. Treatment with 
non-steroidal anti-inflammatory drugs was avoided 
during the perioperative period. Low molecular weight 
heparin administration (40 mg enoxaparin sodium 
[clexane]/day) was started one day prior to the surgical 
intervention and was continued for five weeks to prevent 
thromboembolism. Intraoperative and postoperative 
period was uneventful due to our efforts. Operation time 
was 140 minutes, estimated blood loss was 200 mL, thus 
transfusion was not indicated. The histology revealed 
pT3a, N0 Gleason score 4+3=7 prostate adenocarcinoma 
with negative surgical margins. Postoperative PSA 
level was under 0.2 ng/ml, eighteen months after the 
operation the patient had no biochemical or clinical 
relapse.
DIscUssION
The hemostatic system secures the constant blood 
flow and prevents bleeding from the vascular system. 
The imbalance between procoagulant and anticoagulant 
activity – caused by diseases, or medical interventions 
– will lead to thromboembolism or hemorrhage. The 
severity of the disease will determine the severity of the 
changes in the hemostatic system.
Factor XI deficiency is an autosomal hereditary blood 
coagulation disorder, which affects both men and women. 
Figure 1: Essential steps to prevent bleeding: (a) Early ligation 
of Santorini’s plexus, (b) Usage of an ultrasonic and bipolar 
instrument during dissection of the bladder neck, (c-d) Usage 
of polymer clips during the dissection of prostate pedicle.
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Unlike hemophilia A and B, spontaneous bleeding is 
rare, but severe bleeding can occur after traumas and 
surgical procedures [2–3]. Bleeding tendency in factor 
XI deficiency do not correlate with the factor XI level, 
therefore the optimal treatment should be determined 
by the clinical course and individual circumstances [4–
5]. A retrospective analysis of bleeding complications 
in patients with factor XI deficiency revealed that 
extent and severity of the surgery influences the risk 
of bleeding. Operations in sites without fibrinolytic 
activity, like orthopedic procedures and appendectomy, 
are less likely to be complicated by bleeding. While 
surgery in areas with fibrinolytic activity increases the 
risk of bleeding, like tonsillectomy, dental extraction 
and prostatectomy [6]. Potential treatment options are 
the fibrinolytic inhibitor tranexamic acid, the synthetic 
vasopressin analogue desmopressin, fresh frozen plasma, 
recombinant coagulation factor VII and coagulation 
factor XI concentrates. In certain cases with partial 
deficiency, only observation can be sufficient [7].
Radical prostatectomy is a procedure when severe 
bleeding requiring transfusion can occur even without 
any bleeding disorder. Prostate is well supplied with 
vessels and it locates close to the Santorini’s venous 
plexus, which can result in significant blood loss 
during the procedure. In contrast with open procedure 
magnification and increased intra-abdominal pressure 
during laparoscopy can reduce blood loss performed by 
experienced laparoscopic surgeon. So experience in the 
field of laparoscopy has a key role to prevent any major 
complications as proven by a comparative study [8]. 
Venous thromboembolism is the most common cause 
of death after pelvic cancer surgery. Radical prostatectomy 
carries a significant risk (ranging 0.8–6.2%) of potentially 
fatal thromboembolism event as proven by a recent study 
[9]. Thus keeping the balance between procoagulant and 
anticoagulant activity is the challenging part in cases 
of radical prostatectomy of factor XI deficiency, hence 
thrombosis prophylaxis should be considered as well.
cONcLUsION
In conclusion, despite the high risk of hemorrhage, 
laparoscopic radical prostatectomy is a feasible 
procedure even in a patient with factor XI deficiency, 
providing that the patient receive adequate preparation 
and a meticulously performed operation carried out by an 
experienced surgeon.
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